United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025

November 2017 | 125 pages | ID: U55ECFE7C9EEN
DPI Research

Abstracts

United States Proton Therapy market is expected to reach nearly US$ 1 Billion, potentially US$7 Billion by 2025.

Market growth can be attributed to factors such as rising cancer incidence, increasing number of proton therapy centers,decreasing cost of proton therapy treatment,technological advances and market adoption.However, high costs involved in the establishment of the center is likely to restrain growth in the forecast period.

The research report titled “United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 - 2025” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States actual and potential proton therapy market.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025.A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company.The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.

The report further sheds light on the number of treatment rooms,current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at US proton therapy centers from 2008 to 2015.

The report also includes assessment of US reimbursement scenario, proton therapy clinical trialsand offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensingand development agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the US proton therapy market.

The report concludes with the profiles of major players in the USproton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio,US proton therapy centers developed by the companies and recent development & trends of the proton therapy market.

Key Highlights of the United States Proton Therapy Market Report:

• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis: By Company
• Market Size & Analysis: United States Proton Therapy (2012 – 2025)
• Market Opportunity Assessment: United States Proton Therapy (2012 – 2025)
• United States Number of Treatment Rooms and Forecast (2012 – 2025)
• United States Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
• United States Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
• United States Number of Patients Treated at Proton Therapy Centers (2008 – 2015)
• United States Proton Therapy Reimbursement Scenario
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Proton Therapy Market – Major Deals
• Key Market Drivers and Inhibitors of the United States Proton Therapy Market
• Major Companies Analysis

Key Companies Covered in the Report are as follows:

• Optivus
• Hitachi
• Ion Beam Applications(IBA)
• Varian Medical Systems
• Mevion Medical Systems

Contents

1. EXECUTIVE SUMMARY

2. WHAT IS PROTON THERAPY?

3. PROTON THERAPY CURRENT APPLICATIONS

4. PROTON THERAPY COMPARATIVE ANALYSIS

4.1 Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
4.2 Proton Therapy Competitive Analysis: By Company

5. MARKET SIZE & ANALYSIS: UNITED STATES PROTON THERAPY (2012 – 2025)

5.1 Proton Therapy Patients Treated Statistics (Volume)
5.2 Proton Therapy Market Analysis (Value)

6. MARKET OPPORTUNITY ASSESSMENT: UNITED STATES PROTON THERAPY (2012 – 2025)

6.1 Potential Proton Therapy Patient Base (Volume)
6.2 Potential Proton Therapy Market Demand Analysis (Value)

7. KEY MARKET DRIVERS AND INHIBITORS OF THE UNITED STATES PROTON THERAPY MARKET

7.1 Market Drivers
7.2 Market Inhibitors

8. UNITED STATES NUMBER OF TREATMENT ROOMS AND FORECAST (2012 – 2025)

9. UNITED STATES PROTON THERAPY CENTER (INSTALLED BASE) AND TREATMENT ROOM MARKET SHARE: BY COMPANY

9.1 Proton Therapy Center (Installed Base) Market Share
9.2 Treatment Room Market Share

10. UNITED STATES PROTON THERAPY CENTER INFRASTRUCTURE ANALYSIS: TREATMENT ROOMS & PROTON THERAPY ACCELERATOR

10.1 Current Proton Therapy Centers
10.2 Demand for Proton Therapy Centers

11. UNITED STATES NUMBER OF PATIENTS TREATED AT PROTON THERAPY CENTERS (2008 – 2015)

12. UNITED STATES PROTON THERAPY REIMBURSEMENT SCENARIO

13. PROTON THERAPY CENTER COMPONENT ANALYSIS

13.1 Proton Accelerator
13.2 Beam Transport System
13.3 Beam Delivery System
13.4 Nozzle
13.5 Treatment Planning System
13.6 Image Viewers
13.7 Patient Positioning System (PPS)
13.8 Human Resource

14. PROTON THERAPY CLINICAL TRAIL INSIGHT BY PHASE, INSTITUTE & COUNTRY

14.1 Year 2017
14.2 Year 2016

15. PROTON THERAPY MARKET – MAJOR DEALS

15.1 Collaboration Deals
15.2 Licensing Agreement
15.3 Exclusive Agreement
15.4 Partnership Deals
15.5 Venture Capital Investment
15.6 Development Agreement

16. KEY COMPANIES ANALYSIS

16.1 Ion Beam Applications(IBA)
  16.1.1 Company Overview
  16.1.2 Product Portfolios
  16.1.3 United States Proton Therapy Centers Developed by IBA
  16.1.4 Recent Development
16.2 Hitachi
  16.2.1 Company Overview
  16.2.2 Product Portfolios
  16.2.3 United States Proton Therapy Centers Developed by Hitachi
  16.2.4 Recent Development
16.3 Varian Medical Systems
  16.3.1 Company Overview
  16.3.2 Product Portfolios
  16.3.3 United States Proton Therapy Centers Developed by Varian
  16.3.4 Recent Development
16.4 Mevion Medical Systems
  16.4.1 Company Overview
  16.4.2 Product Portfolios
  16.4.3 United States Proton Therapy Centers Developed by Mevion
  16.4.4 Recent Development
16.5 Optivus
  16.5.1 Company Overview
  16.5.2 Product Portfolios
  16.5.3 United States Proton Therapy Centers Developed by Optivus
  16.5.4 Recent Development

List Of Figures

LIST OF FIGURES:

Figure 5–1: United States Proton Therapy Patients Treated Statistics(Number),2012 – 2017
Figure 5–2: United States Proton Therapy Patients Treated Statistics Forecast (Number),2018 – 2025
Figure 5–3: United States Proton Therapy Market (Million US$), 2012 – 2017
Figure 5–4: United States Proton Therapy Market Forecast (Million US$), 2018 – 2025
Figure 6–1: United States Potential Proton Therapy Patient Base(Thousand),2012 – 2017
Figure 6–2: United States Potential Proton Therapy Patient Base Forecast(Thousand),2018 – 2025
Figure 6–3: United States Potential Proton Therapy Market (Million US$),2012 – 2017
Figure 6–4: United States Potential Proton Therapy Market Forecast (Million US$),2018 – 2025
Figure 7–1: United States – New Cancer Cases Diagnosed with Cancer (Number), 2012 – 2017
Figure 7–2: United States – Forecast for New Cancer Cases Diagnosed with Cancer (Number), 2018 – 2025
Figure 8–1: United States – Number of Treatment Rooms(Number),2012 – 2017
Figure 8–2: United States – Number of Treatment Rooms Forecast (Number),2018 – 2025
Figure 9–1: United States Proton Therapy Center (Installed Base) Market Share,2016
Figure 9–2: United States Proton Therapy Treatment Room Market Share,2016

List Of Tables

LIST OF TABLES:

Table 3–1: Proton Therapy Current Applications
Table 4–1: Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
Table 4–2: Proton Therapy Competitive Analysis by Company
Table 10–1: United States Current Proton Therapy Centers,2017
Table 10–2: United States Proton Therapy Facilities in Under Construction
Table 10–3: United States Proton Therapy Facilities in a Planning Stage
Table 15–1: United States Proton Therapy – Collaboration Deals, 2007 – 2017
Table 15–2: United States Proton Therapy – Licensing Agreement, 2007 – 2015
Table 15–3: United States Proton Therapy – Exclusive Agreement, 2014 – 2015
Table 15–4: United States Proton Therapy – Partnership Deals, 2013 – 2017
Table 15–5: United States Proton Therapy – Venture Capital Investment, 2008 – 2017
Table 15–6: United States Proton Therapy – Development Agreement, 2013 – 2014
Table 16–1: United States Proton Therapy Centers Developed by IBA
Table 16–2: United States Proton Therapy Centers Developed by Hitachi
Table 16–3: United States Proton Therapy Centers Developed by Varian
Table 16–4: United States Proton Therapy Centers Developed by Mevion
Table 16–5: United States Proton Therapy Centers Developed by Optivus